Laura Clague

Insider Reports History

Location
Escondido, CA
Signature
/s/ Laura Clague by Agnieszka Gallagher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laura Clague:

Company Role Class Num Shares Value Price $ Report Date Ownership
Genasys Inc. Director Common Stock 284,311 $525,975 $1.85 27 Apr 2022 Direct
Travere Therapeutics, Inc. Chief Financial Officer Common Stock 35,655 $319,469 $8.96 11 May 2022 Direct
STANDARD BIOTOOLS INC. Director Common Stock 104,791 $266,169 $2.54 14 Jun 2023 Direct
STANDARD BIOTOOLS INC. Director Stock Option (Right to Buy) 35,380 $132,321 $3.74 14 Jun 2023 Direct
Genasys Inc. Director Common Stock 2,000 $3,700 $1.85 27 Apr 2022 spouse
Genasys Inc. Director Stock Option 0 27 Apr 2022 Direct

Insider Reports Filed by Laura Clague

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LAB STANDARD BIOTOOLS INC. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 20:41
LAB STANDARD BIOTOOLS INC. 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 18:04
TVTX Travere Therapeutics, Inc. 10 May 2022 2 -$47,322 4 Chief Financial Officer 12 May 2022, 20:45
GNSS Genasys Inc. 27 Apr 2022 2 +$66,500 4 Director 27 Apr 2022, 19:02
GNSS Genasys Inc. 15 Mar 2022 1 $0 4 Director 17 Mar 2022, 15:36
GNSS Genasys Inc. 23 Feb 2022 3 +$132 4 Director 24 Feb 2022, 12:54
TVTX Travere Therapeutics, Inc. 31 Jan 2022 5 -$33,921 4 Chief Financial Officer 02 Feb 2022, 15:17
TVTX Travere Therapeutics, Inc. 24 Jan 2022 1 -$51,534 4 Chief Financial Officer 26 Jan 2022, 15:34
TVTX Travere Therapeutics, Inc. 10 Jan 2022 2 -$205,500 4 Chief Financial Officer 12 Jan 2022, 15:05
TVTX Travere Therapeutics, Inc. 13 Aug 2021 2 -$24,085 4 Chief Financial Officer 17 Aug 2021, 19:34
LAB FLUIDIGM CORP 25 May 2021 2 $0 4 Director 27 May 2021, 17:28
TVTX Travere Therapeutics, Inc. 11 May 2021 2 -$77,200 4 Chief Financial Officer 13 May 2021, 16:07